Literature DB >> 8548241

Quality-of-life assessment in patients undergoing treatment for oesophageal carcinoma.

D M O'Hanlon1, M Harkin, D Karat, T Sergeant, N Hayes, S M Griffin.   

Abstract

In a prospective study of 69 patients being treated for oesophageal carcinoma, quality of life was assessed with the Rotterdam Symptom Checklist, a dysphagia score and an activities of daily living questionnaire. Significant correlations were found between the results of the Rotterdam Symptom Checklist, the dysphagia score and most aspects of the activities of daily living questionnaire. Eighteen patients underwent surgery, 43 radiotherapy or intubation, and eight a combination of surgery and other therapy. Patients undergoing surgery were significantly younger and had better scores in all parameters examined before operation, including significantly better scores in 'knowledge and communication' and 'mobility and fatigue'. The dysphagia score fell significantly after intervention both in patients undergoing surgery alone and in those receiving palliative therapy. The activities of daily living questionnaire showed significant improvements in two parameters in the surgical group ('self-care' and 'eating and drinking') and in none of the parameters assessed in the palliation group in 16 weeks. Quality-of-life assessment is useful in assessing quality of care and patient well-being after the diagnosis and treatment of oesophageal carcinoma.

Entities:  

Mesh:

Year:  1995        PMID: 8548241     DOI: 10.1002/bjs.1800821232

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

Review 1.  Management of upper gastrointestinal cancers.

Authors:  A Melville; E Morris; D Forman; A Eastwood
Journal:  Qual Health Care       Date:  2001-03

2.  Longitudinal Quality-of-Life Analysis of RTOG 94-05 (Int 0123):A Phase III Trial of Definitive Chemoradiotherapy for Esophageal Cancer.

Authors:  Lisa A Kachnic; Kathryn Winter; Todd Wasserman; David Kelsen; Robert Ginsberg; Thomas M Pisansky; James Martenson; Ritsuko Komaki; Gordon Okawara; Seth A Rosenthal; Christopher G Willett; Bruce D Minsky
Journal:  Gastrointest Cancer Res       Date:  2011-03

3.  The prognostic value of quality of life scores during treatment for oesophageal cancer.

Authors:  J M Blazeby; S T Brookes; D Alderson
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

4.  Quality of life associated with surgery for esophageal cancer: differences between collar and intrathoracic anastomoses.

Authors:  Christian E Schmidt; Beate Bestmann; Thomas Küchler; Andreas Schmid; Bernd Kremer
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

Review 5.  Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer.

Authors:  Marc Jacobs; Rhiannon C Macefield; Jane M Blazeby; Ida J Korfage; Mark I van Berge Henegouwen; Hanneke C J M de Haes; Ellen M Smets; Mirjam A G Sprangers
Journal:  Qual Life Res       Date:  2012-10-20       Impact factor: 4.147

Review 6.  Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs).

Authors:  Rhiannon C Macefield; Marc Jacobs; Ida J Korfage; Joanna Nicklin; Robert N Whistance; Sara T Brookes; Mirjam A G Sprangers; Jane M Blazeby
Journal:  Trials       Date:  2014-02-05       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.